Gurugram-based healthcare edtech startup Virohan is set to raise ₹25.7 crore (approximately $3 million) in its ongoing pre-Series B funding round, with Blume Ventures leading the investment. The round also saw participation from existing investors Bharat Inclusive Technologies and Japan-based Rebright Partners, further strengthening Virohan’s investor confidence.
Continued Momentum in Pre-Series B
Virohan had initiated its pre-Series B round in December 2022, raising $7 million in a round also led by Blume Ventures. The current infusion marks a significant step toward expanding its operations and improving service delivery in India’s growing healthcare education market.
As per regulatory filings with the Registrar of Companies (RoC), Virohan’s board approved a special resolution to issue 1,783 pre-Series B3 compulsorily convertible preference shares (CCPS) at a price of ₹1,44,072 per share. The capital raised will be used for general operations, working capital, capital expenditures, and business expansion.
Investment Breakdown and Valuation
Blume Ventures will contribute ₹15 crore, while Bharat Inclusive Technologies and Rebright Partners will invest ₹5.7 crore and ₹5 crore, respectively. Following this allotment, Virohan’s post-money valuation is estimated to reach ₹530 crore (around $62 million), representing a 25% increase from its last funding round.
To date, Virohan has secured over $15 million in total funding. According to data from TheKredible, Blume Ventures will become the largest shareholder with a 15.36% stake. Bharat Inclusive Technologies and Rebright Partners will hold 5.84% and 5.65%, respectively. Co-founders Nalin Saluja, Kunaal Dudeja, and Archit Jayasal will each maintain a 13.6% ownership stake.
About Virohan: Bridging Healthcare Skills Gap
Founded in 2018, Virohan offers vocational training programs for aspiring healthcare professionals across India. Using a hybrid learning model, the startup provides training both online and on-campus in cities like Delhi, Gurugram, Faridabad, Pune, Jaipur, Mumbai, and Nagpur. The company aims to address the growing demand for skilled healthcare workers in India’s Tier 1 and Tier 2 cities.
Financial Growth and Strategic Partnerships
In FY24, Virohan nearly doubled its operating revenue to ₹21 crore from ₹10.65 crore in FY23. While losses also increased by 18% to ₹22 crore, the surge in revenue highlights strong business growth and market demand.
In a strategic move, Virohan recently collaborated with Lenskart to launch SureStart, a training initiative that blends theory with practical learning to prepare students for ophthalmic technician roles, further expanding its industry-focused education offerings.
Editor Desk
Verified JournalistDiscover the latest startup, business, and funding news. Get insights on trends, IPOs, mergers, and acquisitions. Perfect for entrepreneurs, investors.